Your browser doesn't support javascript.
loading
Safety Endpoints With Vadadustat Versus Darbepoetin Alfa in Patients With Non-Dialysis-Dependent CKD: A Post Hoc Regional Analysis of the PRO2TECT Randomized Clinical Trial of ESA-Naïve Patients.
Winkelmayer, Wolfgang C; Arnold, Susan; Burke, Steven K; Chertow, Glenn M; Eckardt, Kai-Uwe; Jardine, Alan G; Lewis, Eldrin F; Luo, Wenli; Matsushita, Kunihiro; McCullough, Peter A; Minga, Todd; Parfrey, Patrick S.
Afiliación
  • Winkelmayer WC; Section of Nephrology, Baylor College of Medicine, Houston, TX.
  • Arnold S; Excellentis Clinical Trial Consultants, South Africa.
  • Burke SK; Akebia Therapeutics Inc, Cambridge, MA.
  • Chertow GM; Division of Nephrology, Stanford University School of Medicine, Palo Alto, CA.
  • Eckardt KU; Department of Nephrology and Medical Intensive Care, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Jardine AG; Department of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
  • Lewis EF; Division of Nephrology, Stanford University School of Medicine, Palo Alto, CA.
  • Luo W; Akebia Therapeutics Inc, Cambridge, MA.
  • Matsushita K; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
  • McCullough PA; Truth for Health Foundation, Tucson, AZ.
  • Minga T; Akebia Therapeutics Inc, Cambridge, MA.
  • Parfrey PS; Division of Nephrology, Memorial University, St John's, Newfoundland, Canada.
Kidney Med ; 5(7): 100666, 2023 Jul.
Article en En | MEDLINE | ID: mdl-37427293

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Kidney Med Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Kidney Med Año: 2023 Tipo del documento: Article